#clinical trial — Friday, June 19, 2026 (1 items)
| 0 | 💬 0 |
Safety and efficacy of GZR18, a long-acting GLP-1 analog, in Chinese patients with type 2 diabetes: A randomized, double-blind, phase 1b/2a trial.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-06-19 | #metabolism #clinical trial #diabetes #drug development |